Lurtotecan Completed Phase 2 Trials for Ovarian Cancer / Fallopian Tube Cancer / Peritoneal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00010179Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer